Cargando…

The relationship between Lp(a) and CVD outcomes: a systematic review

Robust associations between lipoprotein(a) [Lp(a)] and CVD outcomes among general populations have been published in previous studies. However, associations in high risk primary prevention and secondary prevention populations are less well defined. In order to investigate this further, a systematic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Forbes, Carol A., Quek, Ruben G. W., Deshpande, Sohan, Worthy, Gill, Wolff, Robert, Stirk, Lisa, Kleijnen, Jos, Gandra, Shravanthi R., Djedjos, Stephen, Wong, Nathan D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869344/ https://www.ncbi.nlm.nih.gov/pubmed/27184891 http://dx.doi.org/10.1186/s12944-016-0258-8

Ejemplares similares

Systematic Review and Network Meta‐Analysis on the Efficacy of Evolocumab and Other Therapies for the Management of Lipid Levels in Hyperlipidemia
por: Toth, Peter P., et al.
Publicado: (2017)

Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal
por: Büyükkaramikli, Nasuh C., et al.
Publicado: (2017)

Fenfluramine for Treating Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Wijnen, Ben, et al.
Publicado: (2022)

Lipid-lowering treatment patterns among patients with type 2 diabetes mellitus with high cardiovascular disease risk
por: Quek, Ruben G W, et al.
Publicado: (2015)

Durvalumab for the Treatment of Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Witlox, Willem J. A., et al.
Publicado: (2019)

Lenalidomide for the Treatment of Low- or Intermediate-1-Risk Myelodysplastic Syndromes Associated with Deletion 5q Cytogenetic Abnormality: An Evidence Review of the NICE Submission from Celgene
por: Blommestein, Hedwig M., et al.
Publicado: (2015)

Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Ramaekers, Bram L. T., et al.
Publicado: (2018)

Productivity loss and indirect costs associated with cardiovascular events and related clinical procedures
por: Song, Xue, et al.
Publicado: (2015)

Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: a retrospective cohort study
por: Fox, Kathleen M., et al.
Publicado: (2016)

Systematic Review of Low‐Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia
por: Wang, Anthony, et al.
Publicado: (2016)

Lp(a)-cholesterol is associated with HDL-cholesterol in overweight and obese African American children and is not an independent risk factor for CVD
por: Sharma, Sushma, et al.
Publicado: (2012)

Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Ramaekers, Bram L. T., et al.
Publicado: (2018)

Belimumab for Treating Active Autoantibody-Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Otten, Thomas, et al.
Publicado: (2022)

Correction: Belimumab for Treating Active Autoantibody‑Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Otten, Thomas, et al.
Publicado: (2023)

Trifluridine–Tipiracil for Previously Treated Metastatic Colorectal Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Ramaekers, Bram L. T., et al.
Publicado: (2017)

The Relationship between Intracarotid Plaque Neovascularization and Lp (a) and Lp-PLA2 in Elderly Patients with Carotid Plaque Stenosis
por: Sun, Chang, et al.
Publicado: (2022)

A Retrospective Study to Examine Healthcare Costs Related to Cardiovascular Events in Individuals with Hyperlipidemia
por: Henk, Henry J., et al.
Publicado: (2015)

A systematic review of the prevalence of DNA damage response gene mutations in prostate cancer
por: Lang, Shona H., et al.
Publicado: (2019)

Ticagrelor for Secondary Prevention of Atherothrombotic Events After Myocardial Infarction: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Pouwels, Xavier G. L. V., et al.
Publicado: (2018)

Elevated Lp(a) and course of COVID-19: Is there a relationship?
por: Pawlos, Agnieszka, et al.
Publicado: (2022)

Epidemiology of Chronic Pain in Denmark and Sweden
por: Harker, Julie, et al.
Publicado: (2012)

Erratum to: ‘Costs of treating cardiovascular events in Germany: a systematic literature review’
por: Schmid, Tamara, et al.
Publicado: (2016)

Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance
por: Westwood, Marie, et al.
Publicado: (2017)

Systematic review and mixed treatment comparison of intravitreal aflibercept with other therapies for diabetic macular edema (DME)
por: Korobelnik, Jean-Francois, et al.
Publicado: (2015)

Medical costs associated with cardiovascular events among high-risk patients with hyperlipidemia
por: Bonafede, Machaon M, et al.
Publicado: (2015)

Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal
por: Ramaekers, Bram L. T., et al.
Publicado: (2016)

Lp(a) and the Risk for Cardiovascular Disease: Focus on the Lp(a) Paradox in Diabetes Mellitus
por: Kostner, Karam M., et al.
Publicado: (2022)

A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of BRCA-mutated breast cancer
por: Forbes, Carol, et al.
Publicado: (2019)

The Relationship Between Periodontal Disease (Pd) and Cardiovascular Disease (Cvd).
por: Trevisan, Maurizio, et al.
Publicado: (2010)

Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Büyükkaramikli, Nasuh C., et al.
Publicado: (2017)

lpGBT Status and Plans
por: Kulis, Szymon Krzysztof
Publicado: (2018)

LEP dominates LP-HEP
Publicado: (1991)

SCLE-LP OVERLAP SYNDROME
por: Sekar, C Shanmuga, et al.
Publicado: (2011)

LP-HEP 91 opening
por: Rubbia, Carlo
Publicado: (1991)

New classes of Lp-spaces
por: Bourgain, Jean
Publicado: (1981)

lpGBT documentation: release
por: Moreira, Paulo, et al.
Publicado: (2022)

Function theory and Lp spaces
por: Cheng, Raymond, et al.
Publicado: (2020)

Study on the relationship between hormone and Lp(a) in Chinese overweight/obese patients
por: Chang, Xiaona, et al.
Publicado: (2022)

Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world setting
por: Bonafede, Machaon, et al.
Publicado: (2013)

Patient-level costs of major cardiovascular conditions: a review of the international literature
por: Nicholson, Gina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dk7fankifbms9k1ea0ia8bhqce